Current Gastroenterology Reports

, Volume 6, Issue 1, pp 37–43

Hepatocellular carcinoma: Updates in primary prevention

  • Will J. FechtJr
  • Alex S. Befeler
Article

Abstract

Hepatocellular carcinoma is a significant cause of mortality worldwide and a growing problem in the United States. Treatment options are often limited, and median survival is less than 1 year. Thus, prevention may provide the best opportunity to alter the natural history of this disease. Primary prevention is best exemplified by the successes of such public health measures as universal hepatitis B vaccination. Such antiviral therapies as interferon may also have a role. Lessons can be learned from complementary and alternative medicine. Nevertheless, more work is needed in understanding hepatocarcinogenesis and in developing models to assess potential chemopreventive agents.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Will J. FechtJr
    • 1
  • Alex S. Befeler
    • 1
  1. 1.Division of Gastroenterology and HepatologySaint Louis University School of MedicineSt. LouisUSA

Personalised recommendations